AKT1 and cancer: Several studies have focused on the zinc-related transporter SLC30 or SLC39 (ZIP) family in cancer, reporting that abnormal Zn2+ in cancer cells caused by abnormal zinc transporters can affect AKT/PTEN and ERK/MAPK pathways (Zhu et al., 2021; Prasad et al., 2022).